GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » Buildings And Improvements

Mankind Pharma (BOM:543904) Buildings And Improvements : ₹0 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma Buildings And Improvements?

Mankind Pharma's annual buildings and improvements declined from Mar. 2022 (₹6,014 Mil) to Mar. 2023 (₹0 Mil) but then stayed the same from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹0 Mil).

Mankind Pharma Buildings And Improvements Historical Data

The historical data trend for Mankind Pharma's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mankind Pharma Buildings And Improvements Chart

Mankind Pharma Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Buildings And Improvements
5,649.02 5,889.71 6,014.21 - -

Mankind Pharma Quarterly Data
Mar20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Mankind Pharma Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

Mankind Pharma (BOM:543904) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » Buildings And Improvements
Comparable Companies
NSE:TORNTPHARM BOM:532321 BOM:500257 BOM:500124 NSE:AUROPHARMA NSE:DIVISLAB NSE:ALKEM BOM:524494 BOM:532331 BOM:506943 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
MANKIND:India
Address
262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020
Website
https://www.mankindpharma.com
Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.

Mankind Pharma (BOM:543904) Headlines

No Headlines